Variable | Regression coefficient | Standard error | Wald | P value | OR value(%95CI) | |
---|---|---|---|---|---|---|
Sex | Female | 1 | ||||
Male | 0.67 | 0.18 | 14.13 | <0.01 | 1.96(1.38–2.79) | |
Mode of transmission | Sexual transmission | 1 | ||||
Injection drugs | −.05 | 0.16 | 0.09 | 0.77 | 0.95(0.70–1.31) | |
the first CD4+counts (counts/μl) | 12.63 | <0.01 | ||||
Below 200 | 1 | |||||
200–349 | −1.2 | 0.19 | 0.43 | 0.51 | 0.89(0.61–1.28) | |
350–499 | −0.34 | 0.20 | 3.02 | 0.08 | 0.71(0.49–1.05) | |
500 and above | −0.62 | 0.20 | 9.67 | <0.01 | 0.54(0.37–0.80) | |
initial ART regimen | Non-TDF + 3TC regimen | 1 | ||||
TDF + 3TC regimen | −0.51 | 0.33 | 2.39 | 0.12 | 0.60(0.32–1.15) | |
time on ART | 3.41 | 0.33 | ||||
6 months-2 years | 1 | |||||
3–5 years | 0.09 | 0.16 | 0.34 | 0.56 | 1.10(0.80–1.50) | |
6–8 years | 0.34 | 0.20 | 2.82 | 0.09 | 1.41(0.95–2.09) | |
≥9 years | −0.17 | 0.37 | 0.22 | 0.64 | 0.84(0.41–1.74) |